Who is sponsoring NCT00845598?

NCT00845598 is sponsored by University of Dundee.

What condition does NCT00845598 study?

NCT00845598 studies Allergic Rhinitis.

What drugs are being tested in NCT00845598?

Interventions: Azelastine , fluticasone, Fluticasone propionate.

What is the status of NCT00845598?

NCT00845598 is currently WITHDRAWN.

Last reviewed 2012-06-11 · How we verify

A Proof of Concept Study to Evaluate Comparative Efficacy of an Azelastine/Fluticasone Combination Nasal Spray vs. Twice the Dose of Fluticasone in Persistent Allergic Rhinitis

NCT00845598 Phase 4 WITHDRAWN

The purpose of this study is to see how a combination spray of azelastine and fluticasone (antihistamine and steroid) compares with a steroid nasal spray (fluticasone) alone in allergic rhinitis i.e. does azelastine permit the use of lesser steroid dose (steroid sparing effect) to achieve the same benefit.

Details

Lead sponsor	University of Dundee
Phase	Phase 4
Status	WITHDRAWN
Start date	2010-08
Completion	2011-08

Conditions

Allergic Rhinitis

Interventions

Azelastine , fluticasone
Fluticasone propionate

Primary outcomes

Maximum percentage fall in PNIF after 400mg/ml of AMP nasal challenge between both groups. — 0, 2 weeks, 4 weeks, 6 weeks, 8 weeks

Countries

United Kingdom